The current valuation score of Tarsus Pharmaceuticals Inc is 9.30, ranking 37 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -81.54, which is -95.86% below the recent high of -3.38 and 0.00% above the recent low of -81.54.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.